Accordingly, activation of GPR30 has clinical value in the protecting brain tissue, and GPR30 also provides new ideas for estrogen replacement therapy in cerebral ischemia (Prossnitz et al., 2008). The gene discussed is GPER1; the disease is brain ischemia.